# Etanercept for Treatment of Hidradenitis

> **NCT00107991** · PHASE2 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 15 (actual)

## Conditions studied

- Hidradenitis Suppurativa

## Interventions

- **DRUG:** etanercept

## Key facts

- **NCT ID:** NCT00107991
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** 2008-08
- **Final completion:** 2008-11
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2018-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00107991

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00107991, "Etanercept for Treatment of Hidradenitis". Retrieved via AI Analytics 2026-08-23 from https://api.ai-analytics.org/clinical/NCT00107991. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*